Curran Simpson is CTO & VP at REGENXBIO Inc. (RGNX). They have made 17 open-market trades across 2 companies since 2009, most recently 2026-07-01.
CIK 0001346164
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 17 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RGNX | SELL · 10b5-1 | 2025-10-09 | 2025-10-10 | $12.62 | $525K | +7.6% | -2.7% | +32.4% |
| RGNX | SELL · 10b5-1 | 2025-09-29 | 2025-10-01 | $10.03 | $153K | +15.6% | +30.2% | +43.6% |
| RGNX | SELL · 10b5-1 | 2025-09-10 | 2025-09-12 | $10.02 | $155K | +3.8% | +23.4% | +39.8% |
| RGNX | SELL · 10b5-1 | 2024-08-01 | 2024-08-05 | $15.00 | $2K | -0.9% | -9.9% | -30.0% |
| RGNX | SELL · 10b5-1 | 2024-07-29 | 2024-07-30 | $15.04 | $290K | -18.3% | -16.1% | -34.4% |
| RGNX | SELL | 2021-01-12 | 2021-01-14 | $50.01 | $1.2M | -16.0% | -6.6% | -28.6% |
| RGNX | SELL | 2021-01-07 | 2021-01-11 | $50.01 | $519K | -10.0% | -1.0% | -29.8% |
| RGNX | SELL | 2020-02-10 | 2020-02-12 | $50.28 | $5.7M | -10.3% | -45.6% | -23.7% |
| RGNX | SELL | 2020-02-05 | 2020-02-07 | $50.00 | $282K | +10.2% | -26.8% | -16.2% |
| RGNX | SELL | 2020-01-17 | 2020-01-21 | $50.00 | $296K | -6.3% | +15.7% | -21.9% |
| RGNX | SELL | 2019-12-09 | 2019-12-11 | $43.74 | $1.4M | +3.9% | +11.8% | -8.3% |
| RGNX | SELL | 2019-05-28 | 2019-05-30 | $50.00 | $900K | +8.9% | +18.9% | -22.1% |
| RGNX | SELL | 2019-02-25 | 2019-02-27 | $54.05 | $286K | +1.8% | +3.2% | -11.9% |
| RGNX | SELL | 2019-02-05 | 2019-02-07 | $50.08 | $2.2M | +7.5% | +31.4% | +6.1% |
| RGNX | SELL | 2019-02-05 | 2019-02-07 | $50.08 | $2.2M | +7.5% | +31.4% | +6.1% |
| RGNX | SELL | 2018-11-16 | 2018-11-20 | $63.88 | $3.9M | -1.8% | -33.8% | -23.8% |
| RGNX | SELL | 2018-10-16 | 2018-10-18 | $60.85 | $7.6M | -0.7% | -4.0% | -29.1% |
| RGNX | SELL | 2018-03-13 | 2018-03-15 | $33.00 | $825K | -5.5% | +23.0% | +84.5% |
| RGNX | SELL | 2017-12-22 | 2017-12-27 | $33.03 | $991K | -24.3% | -15.8% | -16.1% |
| RGNX | SELL | 2017-12-07 | 2017-12-11 | $30.04 | $1.3M | +6.1% | -5.2% | +9.8% |
| RGNX | SELL · 10b5-1 | 2017-12-04 | 2017-12-06 | $30.00 | $3K | +1.4% | -5.8% | +0.0% |
| RGNX | SELL | 2017-11-27 | 2017-11-29 | $29.31 | $59K | +7.9% | +21.6% | +6.8% |
| HGSI | SELL · 10b5-1 | 2011-06-01 | 2011-06-02 | $27.11 | $621K | N/A | N/A | N/A |
| HGSI | SELL · 10b5-1 | 2011-04-29 | 2011-05-02 | $28.99 | $812K | N/A | N/A | N/A |
| HGSI | SELL · 10b5-1 | 2010-10-01 | 2010-10-04 | $29.79 | $682K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.